Clinical Trials · NCT01790308
Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Sun Yat-sen University
- Enrollment
- 100
- Start date
- Feb 2013
- Locations
- See registry
- Primary endpoint
- the percentage of the patients who maintain glucose control 1 year after short intensive therapy